Background: The resumption of menses (ROM) is considered an important clinical marker in weight restoration for patients with anorexia nervosa (AN). The purpose of this study was to examine ROM in relation to expected body weight (EBW) and psychosocial markers in adolescents with AN.

Methods: We conducted a retrospective chart review at The University of Chicago Eating Disorders Program from September 2001 to September 2011 (N = 225 females with AN). Eighty-four adolescents (Mean age = 15.1, SD = 2.2) with a DSM-IV diagnosis of AN, presenting with secondary amenorrhea were identified. All participants had received a course of outpatient family-based treatment (FBT), i.e., ~20 sessions over 12 months. Weight and menstrual status were tracked at each therapy session throughout treatment. The primary outcome measures were weight (percent of expected for sex, age and height), and ROM.

Results: Mean percent EBW at baseline was 82.0 (SD = 6.5). ROM was reported by 67.9% of participants (57/84), on average at 94.9 (SD = 9.3) percent EBW, and after having completed an average of 13.5 (SD = 10.7) FBT sessions (~70% of standard FBT). Compared to participants without ROM by treatment completion, those with ROM had significantly higher baseline Eating Disorder Examination Global scores (p = .004) as well as Shape Concern (p < .008) and Restraint (p < .002) subscale scores. No other differences were found.

Conclusions: Results suggest that ROM occur at weights close to the reference norms for percent EBW, and that high pre-treatment eating disorder psychopathology is associated with ROM. Future research will be important to better understand these differences and their implications for the treatment of adolescents with AN.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053648PMC
http://dx.doi.org/10.1186/2050-2974-1-12DOI Listing

Publication Analysis

Top Keywords

resumption menses
8
anorexia nervosa
8
family-based treatment
8
percent ebw
8
rom
5
menses anorexia
4
nervosa course
4
course family-based
4
treatment
4
treatment background
4

Similar Publications

Abstract: Chemotherapeutic agents result in the loss of growing follicles, which can manifest as amenorrhoea. Alkylating chemotherapy (AC) is known to be more gonadotoxic than non-alkylating chemotherapy (NAC). Anti-Müllerian hormone (AMH), an indirect marker of ovarian reserve, and age have been investigated as predictors of ovarian function after chemotherapy; however, little is known about the time to return of menses.

View Article and Find Full Text PDF

Background: Previous studies have suggested that acupuncture could improve the clinical outcomes of women with premature ovarian insufficiency (POI) and polycystic ovary syndrome (PCOS). However recent meta-analyses have provided inconclusive findings. This umbrella meta-analysis aimed to explore the effect of acupuncture therapies on PCOS and POI outcomes.

View Article and Find Full Text PDF

Folliculogenesis resumption after ovarian cortex transplantation: what is the earliest hormonal indicator?

Arch Gynecol Obstet

December 2024

Department of Assisted Reproductive Technologies and Fertility Preservation, Jeanne de Flandre Hospital, CHU Lille, 59000, Lille, France.

Introduction: Ovarian tissue cryopreservation (OTC) is recommended by scientific societies for women undergoing highly gonadotoxic cancer treatments. Following transplantation, the restoration of ovarian function is typically characterised by the resumption of spontaneous menstruation. Yet, a few studies have looked at the longitudinal hormonal variations following transplantation.

View Article and Find Full Text PDF
Article Synopsis
  • A multicenter study was conducted to assess the effects of self-crosslinked hyaluronic acid (SCH) gel on endometrial recovery in 382 women post-artificial abortion, comparing SCH treatment with a control group.
  • Results showed that the SCH group had significantly greater endometrial thickness and fewer cases of reduced menstrual volume compared to the control group, indicating potential benefits of the gel for recovery.
  • While SCH gel also appeared to reduce dysmenorrhea, this difference was not statistically significant, and overall safety was affirmed with no serious adverse events associated with the treatment.
View Article and Find Full Text PDF

Barriers and enablers to utilisation of postpartum long-acting reversible contraception in Eastern Uganda: a qualitative study.

Contracept Reprod Med

October 2024

Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK.

Article Synopsis
  • In Uganda, many women want to postpone future pregnancies, but the use of postpartum family planning (PPFP) is low, particularly regarding postpartum long-acting reversible contraceptives (LARCs).
  • A qualitative study involving interviews and discussions with postpartum women, partners, and health workers was conducted to investigate the behavioral factors influencing LARC usage in Eastern Uganda.
  • Key findings revealed issues such as women’s lack of knowledge and misconceptions about LARCs, limited health worker capabilities, men's reluctance to engage in family planning decisions, and the need for improved education and support to boost PPFP uptake.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!